Overview

Tracer-Guided Surgery for Recurrent Prostate Cancer

Status:
Not yet recruiting
Trial end date:
2025-11-01
Target enrollment:
Participant gender:
Summary
ADT with or without robot-assisted PSMA-radioguided surgery for patients with recurrent prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
The Netherlands Cancer Institute